Nebraska ephedrine law exempts new Primatene Tablets, Bronkaid Dual Action.
This article was originally published in The Tan Sheet
Executive Summary
NEBRASKA EPHEDRINE LAW EXEMPTS NEW PRIMATENE TABLETS, BRONKAID DUAL ACTION from the controlled substance requirements established as of July 19 for most ephedrine-containing products sold in the state ("The Tan Sheet" July 29, In Brief). The law specifically exempts combination products with 12.5-25 mg ephedrine and 200-400 mg guaifenesin.